Reich K, Korber A, Mrowietz U, Sticherling M, et al. Secukinumab two weekly versus four weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study. Br J Dermatol 2020 Jul 11. doi: 10.1111/bjd.19398.
PMID: 32652528